OpenAI IPO Prospects and Private Growth Capital Strategy Analysis SRPT Sarepta reports far wider Q4 2025 loss than estimates even as its stock notches small gains in todays session VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment CHNR China NatRes publishes quarterly earnings update with full financial metrics and management outlook to be released next week The Southern Company SO Marks 25th Consecutive Dividend Increase Reinforces Defensive Income Investment Thesis SSSS SuRo Capital posts far wider Q4 2025 loss than consensus estimates shares dip 069 percent today